$CSBR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CHAMPIONS ONCOLOGY, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CHAMPIONS ONCOLOGY, INC.. Get notifications about new insider transactions in CHAMPIONS ONCOLOGY, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 08 2021 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Option Exercise | M | 5.43 | 10,000 | 54,300 | 0 | |
| Feb 08 2021 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Option Exercise | M | 3.21 | 10,000 | 32,100 | 0 | |
| Feb 08 2021 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Option Exercise | M | 1.59 | 10,000 | 15,900 | 0 | |
| Feb 08 2021 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Payment of Exercise | F | 11.53 | 8,873 | 102,306 | 81,274 | 72.4 K to 81.3 K (+12.26 %) |
| Feb 08 2021 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Buy | M | 5.43 | 10,000 | 54,300 | 90,147 | 80.1 K to 90.1 K (+12.48 %) |
| Feb 08 2021 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Buy | M | 3.21 | 10,000 | 32,100 | 80,147 | 70.1 K to 80.1 K (+14.26 %) |
| Feb 08 2021 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Buy | M | 1.59 | 10,000 | 15,900 | 70,147 | 60.1 K to 70.1 K (+16.63 %) |
| Feb 08 2021 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Option Exercise | M | 5.43 | 10,000 | 54,300 | 0 | |
| Feb 08 2021 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Option Exercise | M | 3.21 | 10,000 | 32,100 | 0 | |
| Feb 08 2021 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Option Exercise | M | 1.59 | 10,000 | 15,900 | 0 | |
| Feb 08 2021 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Payment of Exercise | F | 11.53 | 8,873 | 102,306 | 81,274 | 72.4 K to 81.3 K (+12.26 %) |
| Feb 08 2021 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Buy | M | 5.43 | 10,000 | 54,300 | 90,147 | 80.1 K to 90.1 K (+12.48 %) |
| Feb 08 2021 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Buy | M | 3.21 | 10,000 | 32,100 | 80,147 | 70.1 K to 80.1 K (+14.26 %) |
| Feb 08 2021 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Buy | M | 1.59 | 10,000 | 15,900 | 70,147 | 60.1 K to 70.1 K (+16.63 %) |
| Dec 17 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Breitfeld Philip P. | Director | Sell | S | 11.35 | 31,443 | 356,976 | 0 | 31.4 K to 0 (-100.00 %) |
| Dec 10 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Option Exercise | A | 11.96 | 10,000 | 119,600 | 10,000 | |
| Dec 10 2020 | CSBR | CHAMPIONS ONCOLOGY ... | SIDRANSKY DAVID | Director | Option Exercise | A | 11.96 | 8,333 | 99,663 | 8,333 | |
| Dec 10 2020 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | A | 11.96 | 16,667 | 199,337 | 16,667 | |
| Dec 10 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Option Exercise | A | 11.96 | 2,500 | 29,900 | 2,500 | |
| Dec 10 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Breitfeld Philip P. | Director | Option Exercise | A | 11.96 | 8,333 | 99,663 | 8,333 | |
| Dec 10 2020 | CSBR | CHAMPIONS ONCOLOGY ... | TOBIN SCOTT R | Director | Option Exercise | A | 11.96 | 10,000 | 119,600 | 10,000 | |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | M | 4.80 | 2,708 | 12,998 | 0 | |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | M | 5.76 | 124,232 | 715,576 | 0 | |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Buy | M | 4.80 | 2,708 | 12,998 | 1,443,928 | 1.4 M to 1.4 M (+0.19 %) |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Buy | M | 5.76 | 124,232 | 715,576 | 1,441,220 | 1.3 M to 1.4 M (+9.43 %) |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Option Exercise | M | 3.21 | 10,000 | 32,100 | 0 | |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Option Exercise | M | 1.59 | 10,000 | 15,900 | 0 | |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Option Exercise | M | 5.46 | 10,000 | 54,600 | 0 | |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Buy | M | 3.21 | 10,000 | 32,100 | 123,121 | 113.1 K to 123.1 K (+8.84 %) |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Buy | M | 1.59 | 10,000 | 15,900 | 113,121 | 103.1 K to 113.1 K (+9.70 %) |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Buy | M | 5.46 | 10,000 | 54,600 | 103,121 | 93.1 K to 103.1 K (+10.74 %) |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Option Exercise | M | 5.76 | 34,375 | 198,000 | 0 | |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Buy | M | 5.76 | 34,375 | 198,000 | 103,121 | 68.7 K to 103.1 K (+50.00 %) |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | CEO | Option Exercise | M | 4.80 | 2,708 | 12,998 | 0 | |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | CEO | Option Exercise | M | 5.76 | 124,232 | 715,576 | 0 | |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | CEO | Buy | M | 4.80 | 2,708 | 12,998 | 964,108 | 961.4 K to 964.1 K (+0.28 %) |
| Nov 03 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | CEO | Buy | M | 5.76 | 124,232 | 715,576 | 961,400 | 837.2 K to 961.4 K (+14.84 %) |
| Oct 30 2020 | CSBR | CHAMPIONS ONCOLOGY ... | TOBIN SCOTT R | Director | Option Exercise | M | 5.46 | 10,000 | 54,600 | 0 | |
| Oct 30 2020 | CSBR | CHAMPIONS ONCOLOGY ... | TOBIN SCOTT R | Director | Buy | M | 5.46 | 10,000 | 54,600 | 10,000 | 0 to 10 K |
| Oct 28 2020 | CSBR | CHAMPIONS ONCOLOGY ... | SIDRANSKY DAVID | Director | Option Exercise | M | 5.46 | 16,667 | 91,002 | 0 | |
| Oct 28 2020 | CSBR | CHAMPIONS ONCOLOGY ... | SIDRANSKY DAVID | Director | Payment of Exercise | F | 9.01 | 10,100 | 91,001 | 748,234 | 758.3 K to 748.2 K (-1.33 %) |
| Oct 28 2020 | CSBR | CHAMPIONS ONCOLOGY ... | SIDRANSKY DAVID | Director | Buy | M | 5.46 | 16,667 | 91,002 | 758,334 | 741.7 K to 758.3 K (+2.25 %) |
| Mar 30 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Buy | P | 5.89 | 300 | 1,767 | 58,746 | 58.4 K to 58.7 K (+0.51 %) |
| Mar 30 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Buy | P | 5.90 | 700 | 4,130 | 58,446 | 57.7 K to 58.4 K (+1.21 %) |
| Mar 30 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Buy | P | 5.97 | 100 | 597 | 57,746 | 57.6 K to 57.7 K (+0.17 %) |
| Mar 30 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Buy | P | 5.99 | 100 | 599 | 57,646 | 57.5 K to 57.6 K (+0.17 %) |
| Mar 30 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Buy | P | 6.00 | 20 | 120 | 57,546 | 57.5 K to 57.5 K (+0.03 %) |
| Mar 26 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Buy | P | 5.50 | 26 | 143 | 57,526 | 57.5 K to 57.5 K (+0.05 %) |
| Mar 26 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | CEO | Sell | S | 5.25 | 75 | 394 | 837,168 | 837.2 K to 837.2 K (-0.01 %) |
| Mar 24 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | CEO | Buy | P | 4.75 | 75 | 356 | 837,243 | 837.2 K to 837.2 K (+0.01 %) |
| Mar 12 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Battery Ventures IX, L.P. | 10% Owner | Option Exercise | X | 5.76 | 286,458 | 1,649,998 | 0 | |
| Mar 12 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Battery Ventures IX, L.P. | 10% Owner | Option Exercise | X | 4.80 | 123,333 | 591,998 | 0 | |
| Mar 12 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Battery Ventures IX, L.P. | 10% Owner | Buy | X | 5.76 | 286,458 | 1,649,998 | 2,421,673 | 2.1 M to 2.4 M (+13.42 %) |
| Mar 12 2020 | CSBR | CHAMPIONS ONCOLOGY ... | Battery Ventures IX, L.P. | 10% Owner | Buy | X | 4.80 | 123,333 | 591,998 | 2,135,215 | 2 M to 2.1 M (+6.13 %) |
| Dec 04 2019 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | M | 2.10 | 1,521 | 3,194 | 0 | |
| Dec 04 2019 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | M | 2.10 | 201,590 | 423,339 | 0 | |
| Dec 04 2019 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Buy | M | 2.10 | 1,521 | 3,194 | 1,316,988 | 1.3 M to 1.3 M (+0.12 %) |
| Dec 04 2019 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Buy | M | 2.10 | 201,590 | 423,339 | 1,315,467 | 1.1 M to 1.3 M (+18.10 %) |
| Nov 06 2019 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Option Exercise | A | 5.43 | 10,000 | 54,300 | 10,000 | |
| Nov 06 2019 | CSBR | CHAMPIONS ONCOLOGY ... | SIDRANSKY DAVID | Director | Option Exercise | A | 5.43 | 8,333 | 45,248 | 8,333 | |
| Nov 06 2019 | CSBR | CHAMPIONS ONCOLOGY ... | Breitfeld Philip P. | Director | Option Exercise | A | 5.43 | 8,333 | 45,248 | 8,333 | |
| Nov 06 2019 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Option Exercise | A | 5.43 | 10,000 | 54,300 | 10,000 | |
| Nov 06 2019 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | A | 5.43 | 16,667 | 90,502 | 16,667 | |
| Nov 06 2019 | CSBR | CHAMPIONS ONCOLOGY ... | TOBIN SCOTT R | Director | Option Exercise | A | 5.43 | 10,000 | 54,300 | 10,000 | |
| Apr 30 2019 | CSBR | CHAMPIONS ONCOLOGY ... | Battery Ventures IX, L.P. | 10% Owner | Option Exercise | X | 4.80 | 58,333 | 279,998 | 0 | |
| Apr 30 2019 | CSBR | CHAMPIONS ONCOLOGY ... | Battery Ventures IX, L.P. | 10% Owner | Buy | X | 4.80 | 58,333 | 279,998 | 2,011,882 | 2 M to 2 M (+2.99 %) |
| Jan 16 2019 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | CEO | Option Exercise | M | 4.80 | 4,167 | 20,002 | 126,940 | |
| Jan 16 2019 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | CEO | Buy | M | 4.80 | 4,167 | 20,002 | 837,168 | 833 K to 837.2 K (+0.50 %) |
| Jan 04 2019 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | M | 4.80 | 4,167 | 20,002 | 1,494,956 | |
| Jan 04 2019 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Buy | M | 4.80 | 4,167 | 20,002 | 1,113,877 | 1.1 M to 1.1 M (+0.38 %) |
| Dec 20 2018 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | CEO | Buy | P | 7.44 | 20,000 | 148,800 | 833,001 | 813 K to 833 K (+2.46 %) |
| Nov 08 2018 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Sell | S | 13.75 | 5,000 | 68,750 | 57,500 | 62.5 K to 57.5 K (-8.00 %) |
| Nov 05 2018 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Option Exercise | A | 12.73 | 10,000 | 127,300 | 10,000 | |
| Nov 05 2018 | CSBR | CHAMPIONS ONCOLOGY ... | Breitfeld Philip P. | Director | Option Exercise | A | 12.73 | 8,333 | 106,079 | 8,333 | |
| Nov 05 2018 | CSBR | CHAMPIONS ONCOLOGY ... | TOBIN SCOTT R | Director | Option Exercise | A | 12.73 | 10,000 | 127,300 | 10,000 | |
| Nov 05 2018 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | A | 12.73 | 16,667 | 212,171 | 16,667 | |
| Nov 05 2018 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Option Exercise | A | 12.73 | 10,000 | 127,300 | 10,000 | |
| Nov 05 2018 | CSBR | CHAMPIONS ONCOLOGY ... | SIDRANSKY DAVID | Director | Option Exercise | A | 12.73 | 8,333 | 106,079 | 8,333 | |
| Oct 15 2018 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | CEO | Gift | G | 12.34 | 303,581 | 3,746,190 | 813,001 | 1.1 M to 813 K (-27.19 %) |
| Oct 12 2018 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | M | 2.10 | 100,000 | 210,000 | 0 | |
| Oct 12 2018 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Payment of Exercise | F | 17.47 | 12,021 | 210,007 | 1,109,710 | 1.1 M to 1.1 M (-1.07 %) |
| Oct 12 2018 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Buy | M | 2.10 | 100,000 | 210,000 | 1,121,731 | 1 M to 1.1 M (+9.79 %) |
| Oct 05 2018 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Sell | S | 13.02 | 8,333 | 108,496 | 62,500 | 70.8 K to 62.5 K (-11.76 %) |
| Oct 03 2018 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Sell | S | 17.02 | 22,535 | 383,546 | 1,021,731 | 1 M to 1 M (-2.16 %) |
| Mar 28 2018 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | CEO | Buy | P | 3.62 | 2,300 | 8,319 | 1,116,582 | 1.1 M to 1.1 M (+0.21 %) |
| Mar 28 2018 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | CEO | Buy | P | 3.57 | 2,235 | 7,979 | 1,114,282 | 1.1 M to 1.1 M (+0.20 %) |
| Mar 26 2018 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | CEO | Buy | P | 3.48 | 200 | 697 | 1,112,047 | 1.1 M to 1.1 M (+0.02 %) |
| Mar 26 2018 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | CEO | Buy | P | 3.50 | 440 | 1,540 | 1,111,847 | 1.1 M to 1.1 M (+0.04 %) |
| Mar 26 2018 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | CEO | Buy | P | 3.50 | 60 | 210 | 1,111,407 | 1.1 M to 1.1 M (+0.01 %) |
| Nov 13 2017 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Director | Option Exercise | A | 3.21 | 16,667 | 53,501 | 16,667 | |
| Nov 13 2017 | CSBR | CHAMPIONS ONCOLOGY ... | Breitfeld Philip P. | Director | Option Exercise | A | 3.21 | 8,333 | 26,749 | 8,333 | |
| Nov 13 2017 | CSBR | CHAMPIONS ONCOLOGY ... | TOBIN SCOTT R | Director | Option Exercise | A | 3.21 | 10,000 | 32,100 | 10,000 | |
| Nov 13 2017 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Option Exercise | A | 3.21 | 10,000 | 32,100 | 10,000 | |
| Mar 10 2017 | CSBR | CHAMPIONS ONCOLOGY ... | Breitfeld Philip P. | Director | Option Exercise | A | 1.59 | 45,000 | 71,550 | 45,000 | |
| Nov 16 2016 | CSBR | CHAMPIONS ONCOLOGY ... | Breitfeld Philip P. | Director | Option Exercise | A | 1.59 | 8,333 | 13,249 | 8,333 | |
| Nov 03 2016 | CSBR | CHAMPIONS ONCOLOGY ... | SIDRANSKY DAVID | Director | Option Exercise | A | 1.59 | 16,667 | 26,501 | 16,667 | |
| Nov 03 2016 | CSBR | CHAMPIONS ONCOLOGY ... | Mendelson Daniel Newman | Director | Option Exercise | A | 1.59 | 10,000 | 15,900 | 10,000 | |
| Nov 03 2016 | CSBR | CHAMPIONS ONCOLOGY ... | Poliakoff Abba David | Director | Option Exercise | A | 1.59 | 10,000 | 15,900 | 10,000 | |
| Nov 03 2016 | CSBR | CHAMPIONS ONCOLOGY ... | TOBIN SCOTT R | Director | Option Exercise | A | 1.59 | 10,000 | 15,900 | 10,000 | |
| Nov 01 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 1.60 | 279,177 | 446,683 | 279,177 | |
| Nov 01 2016 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | President | Option Exercise | A | 1.60 | 279,177 | 446,683 | 279,177 | |
| Oct 24 2016 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | President | Buy | P | 1.68 | 10,000 | 16,800 | 1,111,347 | 1.1 M to 1.1 M (+0.91 %) |
| Oct 24 2016 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | President | Buy | P | 1.67 | 10,000 | 16,700 | 1,101,347 | 1.1 M to 1.1 M (+0.92 %) |
| Oct 24 2016 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | President | Buy | P | 1.64 | 10,000 | 16,400 | 1,091,347 | 1.1 M to 1.1 M (+0.92 %) |
| Oct 20 2016 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | President | Buy | P | 1.70 | 10,000 | 17,000 | 1,081,347 | 1.1 M to 1.1 M (+0.93 %) |
| Oct 20 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.70 | 418 | 711 | 1,044,266 | 1 M to 1 M (+0.04 %) |
| Oct 20 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.69 | 381 | 644 | 1,043,848 | 1 M to 1 M (+0.04 %) |
| Oct 20 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.69 | 201 | 340 | 1,043,467 | 1 M to 1 M (+0.02 %) |
| Oct 20 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.70 | 1,000 | 1,698 | 1,043,266 | 1 M to 1 M (+0.10 %) |
| Oct 17 2016 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | President | Buy | P | 1.66 | 10,000 | 16,600 | 1,071,347 | 1.1 M to 1.1 M (+0.94 %) |
| Oct 17 2016 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | President | Buy | P | 1.66 | 305 | 506 | 1,061,347 | 1.1 M to 1.1 M (+0.03 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.65 | 300 | 495 | 1,042,266 | 1 M to 1 M (+0.03 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.66 | 1,000 | 1,658 | 1,041,966 | 1 M to 1 M (+0.10 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.67 | 1,000 | 1,670 | 1,040,966 | 1 M to 1 M (+0.10 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.68 | 1,000 | 1,679 | 1,039,966 | 1 M to 1 M (+0.10 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.68 | 1,000 | 1,677 | 1,038,966 | 1 M to 1 M (+0.10 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.67 | 1,000 | 1,670 | 1,037,966 | 1 M to 1 M (+0.10 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.67 | 1,000 | 1,670 | 1,036,966 | 1 M to 1 M (+0.10 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.69 | 500 | 845 | 1,035,966 | 1 M to 1 M (+0.05 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.68 | 500 | 842 | 1,035,466 | 1 M to 1 M (+0.05 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | President | Buy | P | 1.66 | 9,695 | 16,094 | 1,061,042 | 1.1 M to 1.1 M (+0.92 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | President | Buy | P | 1.66 | 5,643 | 9,367 | 1,051,347 | 1 M to 1.1 M (+0.54 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | President | Buy | P | 1.66 | 4,357 | 7,233 | 1,045,704 | 1 M to 1 M (+0.42 %) |
| Oct 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | President | Buy | P | 1.68 | 10,000 | 16,800 | 1,041,347 | 1 M to 1 M (+0.97 %) |
| Oct 11 2016 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | President | Buy | P | 1.66 | 5,000 | 8,300 | 1,031,347 | 1 M to 1 M (+0.49 %) |
| Oct 11 2016 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | President | Buy | P | 1.66 | 4,537 | 7,531 | 1,026,347 | 1 M to 1 M (+0.44 %) |
| Oct 07 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.64 | 5,000 | 8,200 | 1,034,966 | 1 M to 1 M (+0.49 %) |
| Oct 07 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.61 | 1,500 | 2,421 | 1,029,966 | 1 M to 1 M (+0.15 %) |
| Oct 07 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.62 | 702 | 1,137 | 1,028,466 | 1 M to 1 M (+0.07 %) |
| Oct 07 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.61 | 1,000 | 1,611 | 1,027,764 | 1 M to 1 M (+0.10 %) |
| Sep 26 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.65 | 33 | 54 | 1,026,764 | 1 M to 1 M (0.00 %) |
| Sep 21 2016 | CSBR | CHAMPIONS ONCOLOGY ... | Morris Ronnie | President | Buy | P | 1.58 | 3,000 | 4,740 | 1,021,810 | 1 M to 1 M (+0.29 %) |
| Sep 21 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.73 | 1,000 | 1,729 | 1,026,731 | 1 M to 1 M (+0.10 %) |
| Sep 21 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.70 | 1,000 | 1,700 | 1,025,731 | 1 M to 1 M (+0.10 %) |
| Sep 21 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.63 | 1,000 | 1,628 | 1,024,731 | 1 M to 1 M (+0.10 %) |
| Sep 21 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.64 | 1,000 | 1,640 | 1,023,731 | 1 M to 1 M (+0.10 %) |
| Sep 21 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Buy | P | 1.63 | 1,000 | 1,627 | 1,022,731 | 1 M to 1 M (+0.10 %) |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | D | 4.55 | 100,765 | 458,481 | 0 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | D | 4.92 | 96,283 | 473,712 | 0 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | D | 4.92 | 16,101 | 79,217 | 0 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | D | 4.92 | 112,331 | 552,669 | 0 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | D | 4.92 | 112,331 | 552,669 | 0 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | D | 4.92 | 182,580 | 898,294 | 0 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | D | 4.92 | 182,580 | 898,294 | 0 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 2.10 | 94,405 | 198,251 | 94,405 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 2.10 | 88,470 | 185,787 | 88,470 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 2.10 | 14,552 | 30,559 | 14,552 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 2.10 | 101,521 | 213,194 | 101,521 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 2.10 | 101,521 | 213,194 | 101,521 | |
| Sep 14 2016 | CSBR | CHAMPIONS ONCOLOGY ... | ACKERMAN JOEL | Chief Executive Off ... | Option Exercise | A | 2.10 | 150,795 | 316,670 | 150,795 |